ArticleACS central science2025
Designing Catalysts to Accelerate a Protein-Peptide Assembly-Reaction Cascade.
Article in ACS central science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Translating Nature's Design Rules: How Catalysis and Life Science Guide Molecular Catassembly.JACS Au · 2026Review
- A generalizable covalent car-t platform for solid tumors enabled by oncolytic adenovirus-delivered artificial antigens.Frontiers in immunology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A biological system is rich in dynamic biomolecular assembly reaction cascades mediated by enzymes and molecular chaperones, as represented by the formation of the "chain-mail-like" bacteriophage HK97 capsid that involves sequential events of chaperone-assisted assembly and cross-linking reactions. To shed light on such catalyzed assembly processes, we report an artificial protein-peptide "assembly-reaction" cascade that can be accelerated by rationally designed catalysts. The cascade is inhibited by a tethered SpyTag mutant that blocks SpyCatcher from the subsequent reactions. A designed fusion of calmodulin and sortase can promote the cascade by first binding with M13 at the loop between the SpyTag mutant and SpyCatcher to open the gating via a coil-helix transition. After the SpyTag-SpyCatcher reaction, the catalyst is regenerated by sortase-mediated cyclization that restores the constrained M13 conformation at the loop to release the bounded calmodulin. In the presence of 0.1 equiv of catalyst, the process can be accelerated, increasing the initial rate by ∼12-fold and reducing the half-life by ∼17-fold. With experimentally measured kinetic parameters, we simulated this system through microkinetic modeling, illustrated the contributions of each parameter, and proposed conditions for optimal catalytic performance. As a prototype of artificial catalyzed supramolecular "assembly-reaction" cascades, this work is reminiscent of those catalyzed cascades in nature. Their common features reveal similar underlying physiochemical principles and suggest new avenues to understand and interfere with biological systems.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.